| Etoposide |
20010421 |
ETOPOSIDE "EBEWE", Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
15.72 |
3.14 |
18.86 |
6% |
0.94 |
16.66 |
3.33 |
19.99 |
18% |
2.83 |
19.49 |
3.9 |
23.39 |
|
НСР-3358/29.04.2014 |
13.05.2014 |
13.05.2014 |
Неактивен |
2792 |
| Etoposide |
ІІ-14809/13.11.2006 г. |
ETOPOSIDE "EBEWE", Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
25.7 |
5.14 |
30.84 |
6% |
1.54 |
27.24 |
5.45 |
32.69 |
18% |
4.63 |
31.87 |
6.37 |
38.24 |
|
КЦ-1296/21.01.2010 |
07.02.2010 |
07.02.2010 |
Неактивен |
2792 |
| Etoposide |
ІІ-14809/13.11.2006 г. |
ETOPOSIDE "EBEWE", Concentrate for solution for infusion, 20 mg/ml - 2,5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
7.3 |
1.46 |
8.76 |
9% |
0.66 |
7.96 |
1.59 |
9.55 |
22% |
1.61 |
9.57 |
1.91 |
11.48 |
|
КЦ-1296/21.01.2010 |
07.02.2010 |
07.02.2010 |
Неактивен |
1192 |
| Etoposide |
ІІ-14809/13.11.2006 г. |
ETOPOSIDE "EBEWE", Concentrate for solution for infusion, 20 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
11.3 |
2.26 |
13.56 |
6% |
0.68 |
11.98 |
2.4 |
14.38 |
18% |
2.03 |
14.01 |
2.8 |
16.81 |
|
КЦ-1296/21.01.2010 |
07.02.2010 |
07.02.2010 |
Неактивен |
2337 |
| Etoposide |
II-3876/19.12.2008 |
Etoposide-Teva 20 mg/ml concentrate for solution for infusion, Concentrate for solution for infusion, 100, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie B.V., The Netherlands |
7.82 |
1.56 |
9.38 |
7% |
0.55 |
8.37 |
1.67 |
10.04 |
20% |
1.56 |
9.93 |
1.99 |
11.92 |
Цената е заличена с решение НСР-1585/01.11.2013 |
НСР-1430/10.10.2013 |
25.10.2013 |
25.10.2013 |
Заличен |
2164 |
| Etoposide |
II-3876/19.12.2008 |
Etoposide-Teva 20 mg/ml concentrate for solution for infusion, Concentrate for solution for infusion, 100, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie B.V., The Netherlands |
9.84 |
1.97 |
11.81 |
7% |
0.69 |
10.53 |
2.11 |
12.64 |
20% |
1.97 |
12.5 |
2.5 |
15 |
|
КЦРР-729/07.06.2012 |
31.07.2012 |
31.07.2012 |
Неактивен |
2164 |
| Etoposide |
II-3876/19.12.2008 |
Etoposide-Teva 20 mg/ml concentrate for solution for infusion, Concentrate for solution for infusion, 100, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie B.V., The Netherlands |
11.72 |
2.34 |
14.06 |
8% |
0.94 |
12.66 |
2.53 |
15.19 |
20% |
2.34 |
15 |
3 |
18 |
|
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2164 |
| Etoposide |
1347/28.12.2007 г. |
ETOSID, Concentrate for solution for infusion, 20 mg/ml - 5 ml, -, Pack: 1 |
Cipla (UK) Ltd., Обединено Кралство |
МС Фарма АД, България |
5.67 |
1.13 |
6.8 |
7% |
0.4 |
6.07 |
1.21 |
7.28 |
20% |
1.13 |
7.2 |
1.44 |
8.64 |
промяна на обстоятелства НСР-2875/05.03.2014 |
КЦ-347/17.12.2008 |
20.01.2009 |
20.01.2009 |
Активен |
325 |
| Letrozole |
ІІ-4887/ 15.05.2009 |
Etruzil, Film coated tablet, 2.5, mg, Pack: 30 |
EGIS Pharmaceuticals PLC, Унгария |
Rottendorf Pharma GmbH - Германия; Synthon Hispania S.L. - Испания; Synthon BV - Холандия; Egis Pharmaceuticals PLC, Hungary |
31.9 |
6.38 |
38.28 |
4% |
1.28 |
33.18 |
6.64 |
39.82 |
16% |
5.1 |
38.28 |
7.66 |
45.94 |
корекц. Решение НСР-4456/15.08.2014; Цената се заличава с решение НСР-6965/24.08.2015 (в сила от 16.09.2015) |
НСР-3944/30.06.2014 |
15.07.2014 |
15.07.2014 |
Заличен |
3006 |
| Letrozole |
ІІ-4887/ 15.05.2009 |
Etruzil, Film coated tablet, 2.5, mg, Pack: 30 |
EGIS Pharmaceuticals PLC, Унгария |
Rottendorf Pharma GmbH - Германия; Synthon Hispania S.L. - Испания; Synthon BV - Холандия; Egis Pharmaceuticals PLC, Hungary |
66.42 |
13.28 |
79.7 |
4% |
2.66 |
69.08 |
13.82 |
82.9 |
16% |
10.63 |
79.71 |
15.94 |
95.65 |
|
КЦРР-2396/21.02.2013 |
05.04.2013 |
05.04.2013 |
Неактивен |
3006 |
| Letrozole |
ІІ-4887/ 15.05.2009 г. |
Etruzil, Film coated tablet, 2.5, mg, Pack: 30 |
EGIS Pharmaceuticals PLC, Унгария |
Rottendorf Pharma GmbH - Германия; Synthon Hispania S.L. - Испания; Synthon BV - Холандия; Egis Pharmaceuticals PLC, Hungar |
105.54 |
21.11 |
126.65 |
4% |
4.22 |
109.76 |
21.95 |
131.71 |
16% |
16.89 |
126.65 |
25.33 |
151.98 |
|
КЦРР-648/19.05.2012 |
11.06.2012 |
11.06.2012 |
Неактивен |
3006 |
| Letrozole |
ІІ-4887/15.05.2009 г. |
Etruzil, Film coated tablet, 2.5, mg, Pack: 30 |
EGIS Pharmaceuticals PLC, Унгария |
Rottendorf Pharma GmbH - Германия; Synthon Hispania S.L. - Испания; Synthon BV - Холандия; Egis Pharmaceuticals PLC, Унгария |
122.43 |
24.49 |
146.92 |
6% |
7.35 |
129.78 |
25.96 |
155.74 |
18% |
22.04 |
151.82 |
30.36 |
182.18 |
|
КЦ-1039/20.07.2009 |
11.08.2009 |
11.08.2009 |
Неактивен |
3006 |
| Vildagliptin, Metformin |
EU/1/07/425/003 |
Eucreas, Film coated tablet, 50 mg/850, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
66.62 |
13.32 |
79.94 |
4% |
2.66 |
69.28 |
13.86 |
83.14 |
16% |
10.66 |
79.94 |
15.99 |
95.93 |
|
НСР-7602/26.11.2015; НСР-9936/29.07.2016 |
02.09.2016 |
02.09.2016 |
Активен |
3261 |
| Vildagliptin, Metformin |
EU/1/07/425/003 |
Eucreas, Film coated tablet, 50 mg/ 850 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
67.36 |
13.47 |
80.83 |
4% |
2.69 |
70.05 |
14.01 |
84.06 |
16% |
10.78 |
80.83 |
16.17 |
97 |
|
НСР-7602/26.11.2015 |
12.12.2015 |
12.12.2015 |
Неактивен |
3261 |
| Vildagliptin, Metformin |
EU/1/07/425/009 |
Eucreas, Film coated tablet, 50 mg/ 1000 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
58.67 |
11.73 |
70.4 |
4% |
2.35 |
61.02 |
12.2 |
73.22 |
16% |
9.39 |
70.41 |
14.08 |
84.49 |
|
НСР-8680/06.04.2016. |
22.04.2016 |
22.04.2016 |
Активен |
3093 |
| Vildagliptin, Metformin |
EU/1/07/425/009 |
Eucreas, Film coated tablet, 50 mg/ 1000 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
62.78 |
12.56 |
75.34 |
4% |
2.51 |
65.29 |
13.06 |
78.35 |
16% |
10.04 |
75.33 |
15.07 |
90.4 |
|
НСР-6902/06.08.2015 |
21.08.2015 |
21.08.2015 |
Неактивен |
3093 |
| Vildagliptin, Metformin |
EU/1/07/425/003 |
Eucreas, Film coated tablet, 50 mg/ 850 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
67.61 |
13.52 |
81.13 |
4% |
2.7 |
70.31 |
14.06 |
84.37 |
16% |
10.82 |
81.13 |
16.23 |
97.36 |
|
НСР-4757/02.10.2014 |
16.10.2014 |
16.10.2014 |
Неактивен |
3261 |
| Vildagliptin, Metformin |
EU/1/07/425/009 |
Eucreas, Film coated tablet, 50 mg/ 1000 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
64.23 |
12.85 |
77.08 |
4% |
2.57 |
66.8 |
13.36 |
80.16 |
16% |
10.28 |
77.08 |
15.42 |
92.5 |
|
НСР-4328/05.08.2014 |
20.08.2014 |
20.08.2014 |
Неактивен |
3093 |
| Vildagliptin, Metformin |
EU/1/07/425/003 |
Eucreas, Film coated tablet, 50 mg/ 850 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
68.4 |
13.68 |
82.08 |
4% |
2.74 |
71.14 |
14.23 |
85.37 |
16% |
10.94 |
82.08 |
16.42 |
98.5 |
|
НСР-2545/24.01.2014 |
18.02.2013 |
18.02.2013 |
Неактивен |
3261 |
| Vildagliptin, Metformin |
EU/1/07/425/009 |
Eucreas, Film coated tablet, 50 mg/ 1000 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
64.37 |
12.87 |
77.24 |
4% |
2.57 |
66.94 |
13.39 |
80.33 |
16% |
10.3 |
77.24 |
15.45 |
92.69 |
|
НСР-2138/14.12.2013 |
31.12.2013 |
31.12.2013 |
Неактивен |
3093 |
| Vildagliptin, Metformin |
EU/1/07/425/003 |
Eucreas, Film coated tablet, 50 mg/ 850 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
75.12 |
15.02 |
90.14 |
4% |
3 |
78.12 |
15.62 |
93.74 |
16% |
12.02 |
90.14 |
18.03 |
108.17 |
|
КЦРР-2499/06.03.2013 |
22.03.2013 |
22.03.2013 |
Неактивен |
3261 |
| Vildagliptin, Metformin |
EU/1/07/425/009 |
Eucreas, Film coated tablet, 50 mg/ 1000 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
69.82 |
13.96 |
83.78 |
4% |
2.79 |
72.61 |
14.52 |
87.13 |
16% |
11.17 |
83.78 |
16.76 |
100.54 |
|
КЦРР-2498/06.03.2013 |
22.03.2013 |
22.03.2013 |
Неактивен |
3093 |
| Vildagliptin, Metformin |
EU/1/07/425/009 |
Eucreas, Film coated tablet, 50 mg/ 1000 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
86 |
17.2 |
103.2 |
4% |
3.44 |
89.44 |
17.89 |
107.33 |
16% |
13.76 |
103.2 |
20.64 |
123.84 |
|
КЦ-912/26.05.2009 |
19.06.2009 |
19.06.2009 |
Неактивен |
3093 |
| Vildagliptin, Metformin |
EU/1/07/425/003 |
Eucreas, Film coated tablet, 50 mg/ 850 mg, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
86 |
17.2 |
103.2 |
4% |
3.44 |
89.44 |
17.89 |
107.33 |
16% |
13.76 |
103.2 |
20.64 |
123.84 |
|
КЦ-912/26.05.2009 |
19.06.2009 |
19.06.2009 |
Неактивен |
3261 |
| Levothyroxine sodium |
20010693 |
Euthyrox, Tablet, 0.025, mg, Pack: 30 |
Merck KGaA, Германия |
Merck KGaA, Frankfurter Strasse 250, Darmstadt 64293, Германия |
0.74 |
0.15 |
0.89 |
7% |
0.05 |
0.79 |
0.16 |
0.95 |
20% |
0.15 |
0.94 |
0.19 |
1.13 |
|
НСР-1996/06.12.2013; НСР-9136/27.04.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
2347 |